FindTrial
Sign In

Cystatin C, a Biomarker of AKI, as a Novel Predictor of Pre-term Labor in Severe Pre-eclampsia

Cystatin C, a Biomarker of AKI, as a Novel Predictor of Pre-term Labor in Severe Pre-eclampsia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20180730002
Enrollment
Unknown
Registered
2018-07-30
Start date
2018-07-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia with normal creatinine Cystatin C&#44

Interventions

Twenty&#45
six pregnant women with severe preeclampsia attending labor room for delivery at Her Royal Highness Princess Maha Chakri Sirindhorn Medical Center were included in the present study. All patients had
0.80 mg/dL)
Diagnostic
Third trimester of pregnancy

Sponsors

MSMC Grant contact number 461/2557
Lead Sponsor
MSMC Grant contact number 461/2557
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Data was collected among pregnant women with a maternal age more than 18 years and is in the second half of pregnancy (gestational age >20 weeks). However, we included only severe preeclampsia with gestational age more than 28 week to our cohort.

Exclusion criteria

Exclusion criteria: Those with history or diagnosis of chronic hypertension, placenta previa, gestational diabetes, or chronic kidney disease with serum creatinine levels > 0.8 mg/dl were excluded

Design outcomes

Primary

MeasureTime frame
obstetric outcome at delivery Preterm labor, Low birthweight—

Secondary

MeasureTime frame
Renal outcome third trimester of pregnancy estimated GFR—

Countries

Thailand

Contacts

Public ContactMaethaphan Kitporntheranunt

Faculty of Medicine, SWU

mtp_swu@hotmail.com0867892514

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026